title: Cost-effectiveness of herpes zoster vaccine: flawed assumptions regarding efficacy against postherpetic neuralgia.
authors.forename: Marc
authors.initials: M
authors.lastname: Brisson
authors.forename: James M
authors.initials: JM
authors.lastname: Pellissier
authors.forename: Myron J
authors.initials: MJ
authors.lastname: Levin
mesh_terms: D000368:Aged; D003362:Cost-Benefit Analysis; D006562:Herpes Zoster / Q000517:prevention & control*; D053061:Herpes Zoster Vaccine / Q000191:economics* / Q000276:immunology*; D006801:Humans; D051474:Neuralgia, Postherpetic / Q000191:economics / Q000517:prevention & control*
chemical_list: D053061:Herpes Zoster Vaccine